First Time Loading...

Cigna Corp
NYSE:CI

Watchlist Manager
Cigna Corp Logo
Cigna Corp
NYSE:CI
Watchlist
Price: 357.99 USD 0.99%
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one CI stock under the Base Case scenario is 726.51 USD. Compared to the current market price of 357.99 USD, Cigna Corp is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CI Relative Value
Base Case
726.51 USD
Undervaluation 51%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
19
vs Industry
78
Median 3Y
0.5
Median 5Y
0.5
Industry
2.4
Forward
0.4
More Details
20.3
P/E
P/E
Price to Earnings
20.3
vs History
3
vs Industry
28
Median 3Y
13.5
Median 5Y
13.7
Industry
23.2
Forward
12.6
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
1
vs Industry
39
Median 3Y
1.8
Median 5Y
1.6
Industry
2.2
More Details
N/A
Price/Premiums
Price/Premiums
Price to Premiums
N/A
vs History
vs Industry
57
Median 3Y
0
Median 5Y
0.4
Industry
0.6
More Details

Multiples Across Competitors

CI Competitors Multiples
Cigna Corp Competitors

All Multiples
P/S
P/E
P/B
All Countries
All Countries
Close
Market Cap P/S P/E P/B
US
Cigna Corp
NYSE:CI
104.7B USD 0.5 20.3 2.3
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20 2.2
US
CVS Health Corp
NYSE:CVS
87.1B USD 0.2 10.4 1.1
DE
Fresenius Medical Care AG
XMUN:FME
22B EUR 1.1 44.1 1.6
US
Laboratory Corporation of America Holdings
NYSE:LH
17.5B USD 1.4 40.3 2.2
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR 0.7 -26.3 0.8
US
Quest Diagnostics Inc
NYSE:DGX
15.7B USD 1.7 18.7 2.4
US
DaVita Inc
NYSE:DVA
12.2B USD 1 17.6 11.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.4B EUR 0.6 22.8 0.8
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -34.9
US
Chemed Corp
NYSE:CHE
8.5B USD 3.7 29.9 7.2

See Also

Summary
CI intrinsic value, competitors valuation, and company profile.
DCF Valuation
CI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CI stock valuation using valuation multiples.
Wall Street Estimates
CI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.